Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss but Not on HbA1c in Patients With Type 2 Diabetes

摘要

To examine the effect of combination therapy with canagliflozin plus liraglutide on HbA1c, endogenous glucose production (EGP), and body weight versus each therapy alone.